Clinical
RSSArticles
-
FDA Actions
In this section: The agency approves a new drug for prostate cancer and expands the indication for a non-small cell lung cancer treatment.
-
Influenza A Renders This Year’s Flu Vaccine Ineffective
This year’s flu vaccine was only 36% effective, according to the CDC.
-
What About Aspirin for PCI Patients?
Should clinicians continue using aspirin for patients with prior percutaneous coronary intervention who are undergoing noncardiac surgery? The answer appears to be yes based on the results of a new study from Canada.
-
Comparing Treatments for Cancer-associated VTE
Researchers have determined that edoxaban was noninferior to dalteparin regarding the composite outcome of recurrent VTE or major bleeding, although recurrent VTE was lower and bleeding was higher with edoxaban.
-
Aspirin Matches Xarelto Efficacy Regarding VTE Prophylaxis After Knee or Hip Surgery
The authors of a recent study concluded that among hip or knee arthroplasty patients who receive five days of postoperative rivaroxaban, extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism.
-
Promising News About Zika Vaccine
Clinicians look forward to confirmation of vaccine efficacy in a large population.
-
Influenza Increases Rate of Myocardial Infarction
The proportion of patients who succumb to influenza pneumonia vs. those who incur bacterial pneumonia subsequent to pneumonia vs. all other incident pneumonias that occur concomitantly with flu season is not readily discernible.
-
Obstructive Sleep Apnea: Oral Appliances
The diversity of treatment options currently available should stimulate optimism that the consequences of obstructive sleep apnea can be improved successfully in most patients.
-
Inhaled Corticosteroids and Fracture Risk
Clinicians should strive to use the minimum inhaled corticosteroids necessary to achieve symptomatic improvements in COPD patients.
-
Rivaroxaban vs. Aspirin for Prevention of VTE
Might direct oral coagulants offer some advantage for extended venous thromboembolism (VTE) thromboprophylaxis in patients undergoing knee or hip arthroplasty who are known to suffer an increased risk of VTE in the immediate postoperative period?